Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Breast implant research

This article was originally published in The Gray Sheet

Executive Summary

House Energy & Commerce/Health subcommittee hearing on "The Breast Implant Research and Information Act" (HR 1961), may prompt bill's inclusion in a larger health-related measure this session, Energy & Commerce staffers say. Held Nov. 15, witnesses included National Center for Policy Research for Women and Families Executive Director Diana Zuckerman, MD, and two breast implant recipients. Introduced May 23 by Reps. Roy Blunt (R-Mo.) and Gene Green (D-Texas), the bill requires FDA to provide Congress with regular updates on the status of postmarket evaluations of saline breast implants (1"The Gray Sheet" May 28, 2001, p. 11). Senate companion legislation (S 961) was introduced by Sen. Barbara Boxer May 24...

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts